Products

3billion
3billion
Clinical Decision Support & Reference
3billion leverages AI to automate variant analysis and enhance accuracy in genetic testing for rare disease diagnosis, making insights more accessible.

See all 1 product →

About 3billion

3billion is a healthcare AI company specializing in genetic testing for rare disease diagnosis. Their services aim to provide rapid and accurate diagnostic results, with 3B-GENOME and 3B-EXOME results available within four weeks. The company leverages AI-powered technologies like EVIDENCE, 3Cnet, and 3AS to analyze genetic data. EVIDENCE classifies whole exome sequencing (WES) variants, 3Cnet predicts pathogenicity for variants lacking clear evidence, and 3AS ranks candidate variants based on symptom similarity.

For physicians, 3billion offers a comprehensive approach to diagnosing rare diseases, particularly for patients who have undergone extensive testing without a clear explanation for their symptoms. They provide continuous reanalysis of undiagnosed cases, ensuring that new research and interpretations are applied to patient data over time. The service includes easy ordering, sample kits, clear test reports, and clinical consultation with their genetics team to discuss results, review variants of uncertain significance (VUS), or reinterpret findings based on new symptoms.

Focus Areas

AI-driven genetic diagnostics rare diseases whole exome sequencing whole genome sequencing genomic newborn screening drug discovery variant interpretation

Business Intelligence

TechnologyAI-powered genome interpretation technology, deep learning-based variant interpretation algorithm (3Cnet), AI drug development platform, cloud-native (implied by AWS partnership)

What Physicians Need to Know

AI-driven Genetic Diagnostics
3billion specializes in AI-powered genetic testing for rare disease diagnosis. Their technology, including EVIDENCE, 3Cnet, and 3ASC, helps classify variants, predict pathogenicity, and rank candidate variants by symptom similarity.
Rare Diseases
The company focuses on providing answers for patients who have spent years without a diagnosis, suggesting that a rare disease could be the cause. They offer genetic testing to help identify these conditions.
Whole Exome Sequencing (WES)
They offer 3B-EXOME, with results available within 4 weeks. Their EVIDENCE technology classifies approximately 100,000 WES variants in 5 minutes on average.
Whole Genome Sequencing (WGS)
They offer 3B-GENOME, with results available within 4 weeks.
Genomic Newborn Screening
They offer 3B-NEO for screening.
Variant Interpretation
Their technology includes EVIDENCE for classifying variants based on ACMG criteria (98.4% sensitivity, 99.99% specificity), 3Cnet for predicting pathogenicity of variants lacking evidence, and 3ASC for ranking candidate variants by symptom similarity.
Reanalysis
3billion continuously reanalyzes undiagnosed cases until a diagnosis is found, acknowledging that clinicians may not have time to chase new papers or reinterpret variants themselves.
Turnaround Time
Results for 3B-GENOME and 3B-EXOME are provided within 4 weeks.
Physician Tip

Physicians can benefit from 3billion's rapid turnaround times for 3B-GENOME and 3B-EXOME, receiving results within 4 weeks. Their AI-powered tools like EVIDENCE, 3Cnet, and 3ASC assist in variant interpretation and diagnosis, with geneticists confirming the final diagnosis. The continuous reanalysis of undiagnosed cases is a significant advantage, as it helps identify diagnoses without requiring constant clinician effort. Physicians can also utilize GEBRA™ for free, from VCF to final report, and engage in clinical consultations with 3billion's genetics team for result discussions, VUS reviews, or reinterpretation based on new symptoms.

Products by 3billion

1 product in the directory

3billion
3billion
Clinical Decision Support & Reference
3billion leverages AI to automate variant analysis and enhance accuracy in genetic testing for rare disease diagnosis, making insights more accessible.

Videos

News, demos, and interviews about 3billion.

Loading videos...

Videos load interactively. If none appear, search YouTube for 3billion →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

3billion offers diagnostic products including 3B-GENOME, 3B-EXOME, 3B-VARIANT, and 3B-INTERPRETER.
3billion uses EVIDENCE to classify WES variants, 3Cnet to predict pathogenicity for variants lacking evidence, and 3ASC to rank candidate variants by symptom similarity.
Results for 3B-GENOME and 3B-EXOME are available within 4 weeks.
Yes, 3billion offers a screening product called 3B-NEO.
3billion continuously reanalyzes data from undiagnosed patients until a diagnosis is found.
Clinicians can receive a clear test report and clinical consultation, and can ask about results or request a VUS review.
GEBRA™ is a tool that allows users to go from VCF to a final report, and it can be experienced for free.

Related Companies

GPnotebook is a comprehensive clinical information and educational reference tool designed for healthcare professionals, particularly general practitioners. Established in 2001, it serves as a go-to resource for primary care professionals seeking quick answers to clinical questions during consultations. The platform features over 30,000 concise, evidence-based clinical reference articles, each focused on a specific primary care […]

Vitestro is a company dedicated to redefining diagnostic blood collection through automation. Their flagship product, Aletta®, is the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). Aletta automates the entire diagnostic blood collection process, aiming to set a new standard for efficiency and consistency in phlebotomy. The company addresses global challenges in manual phlebotomy, such as […]

LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]

Intelligent Medical Objects (IMO) Health is an AI-native clinical data intelligence company that provides a foundation for modern health tech use cases. They leverage a clinician-built ontology and intelligent knowledge graph to create accurate, interoperable, and AI-ready data at scale. IMO Health’s solutions are designed to transform fragmented clinical documentation into structured, contextualized data, which […]

Cloudphysician is a health-tech company that provides AI-powered solutions to transform patient care and safety in intensive care units (ICUs) and emergency departments. The company’s proprietary platform, RADAR, acts as an AI video co-pilot for clinicians, integrating live video, vital signs, and Electronic Medical Records (EMRs) to intelligently interpret events in real-time and guide care […]

Exo Imaging is a pioneering healthcare AI company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. The company’s mission is to make high-quality, affordable, and easy-to-use medical imaging accessible to healthcare professionals worldwide, enabling them to make critical, real-time decisions that ultimately improve patient outcomes. Exo’s technology combines advances […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.